Veterinary Infusion Pumps Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Large Volume Infusion Pump, Syringe Infusion Pump), Animal (Small, Large), By End User (Veterinary Hospital & Clinics, Animal Research Centres, Others), and Region Forecast 2020-2031

Veterinary Infusion Pumps Market size was valued at US$ 285.9 million in 2024 and is expected to reach US$ 495 million by 2031, growing at a significant CAGR of 7.4% from 2025-2031. Moreover, the U.S. market is anticipated to witness notable growth, reaching an estimated US$ 125 million by 2031, driven by increasing pet healthcare expenditure, rising awareness about advanced veterinary care, and growing adoption of infusion technologies across veterinary clinics and hospitals.

The worldwide market is increasing steadily with the growing need for accuracy in drug administration in veterinary practice. Pumps are an integral component of critical care in pet and livestock animals, particularly for fluid therapy, pain management, and anaesthesia for surgery. The rising level of pet adoption and expenditure on animal health are fuelling demand for technologically sophisticated, programmable infusion systems. Apart from this, veterinary clinics and hospitals increasingly find it more beneficial to employ automated infusion pumps to deliver drugs repetitively without errors. As veterinary services become standardized and regulated in the developed economies, infusion pumps are transforming into core clinical infrastructure from value-added equipment.

New trends in animal care, such as the establishment of outpatient and mobile veterinary facilities, are redefining demand for portable and easy-to-use infusion pumps. Moreover, increasing prevalence of animal chronic diseases, diabetes, kidney disease, and cancer, and other similar diseases is demanding long-term therapy needs that need to be based on dependable infusion products. Intelligent-connected, battery-powered, and mini-form device products from competitive players are reacting based on the convenience of veterinary workflow, states the report. Support from regulators in the form of stimulating animal health infrastructure enhancements and expanding veterinary pharma R&D is also stimulating market growth. Due to growing care for the welfare of animals worldwide, the market for veterinary infusion pumps will gain momentum in developing as well as developed regions.

Facts & Figures:

• The global trend of companion animal adoption is driving demand for infusion-based therapy and veterinary diagnostics. Higher levels of pet ownership are directly associated with higher volumes of procedures in veterinary medicine.
• Some 920,000 shelter animals are euthanized annually in the U.S., according to 2022 figures from Shelter Animal Count, and 810,000 strays are reclaimed, bearing testimony to more and more animals needing clinical treatments.
• The American Society for the Prevention of Cruelty to Animals (2023) reported 6.3 million companion animals entering U.S. shelters each year, emphasizing rising demand for veterinary health facilities, like infusion therapies.
• In Thailand, Frontiers in Veterinary Science (2022) estimated 12.8 million dogs, of which 11.2 million were domestic pets, signifying rising demand for long-term care and supportive drug delivery systems in Southeast Asia.
• Market expansion is also supported through action plans initiated by governments and private stakeholders. For instance, Merck Animal Health's collaboration with the Street Dog Coalition (March 2022) facilitated free veterinary care for stray dogs, contributing to infusion availability.

Key Developments:

• In April 2025, ICU Medical Inc., a global leader in medical device innovation, announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Plum Solo™ precision IV pump, a single-channel device designed to complement the dual-channel Plum Duo™. The company also secured FDA clearance for enhanced versions of the Plum Duo pump and the LifeShield™ infusion safety software, marking the official launch of the ICU Medical IV Performance Platform. These approvals enable ICU Medical to introduce a new category of precision IV pumps and further expand its comprehensive infusion therapy portfolio.
• In February 2023, Mindray launched its BeneFusion i Series and u Series infusion systems, designed to deliver high precision, adaptive customization, and user-friendly operation to ensure optimal medication safety across diverse clinical environments. These advanced infusion systems reflect Mindray’s commitment to improving infusion therapy standards and are set to be available in selected countries and regions as part of a phased rollout.

Veterinary Infusion Pumps Market Segmentation:

Based on the product:

• Larger Volume Infusion Pump
• Syringe Infusion Pump

The syringe infusion pump market is the present market leader in veterinary infusion pumps because of its higher accuracy and versatility for controlled drug release of small doses the requirement in treating companion animals. They are particularly useful in anaesthesia, pain management, and critical care, where accuracy of dosing would be a matter of difference in patient care. Their small size and minimal maintenance needs make them adaptable to mobile as well as fixed veterinary environments. Further, developments in programmable functionality and safety alarms have enhanced user confidence, while increased demand for accurate therapy in small animal practice continues to spur syringe pump application among veterinary hospitals and clinics. Small animals, such as dogs and cats, account for the largest dominant segment of the market propelled by the increase in pet humanization and companion animal healthcare spending.

Based on the animal:

• Large
• Small

Small animals, particularly dogs and cats, represent the most leading segment in the market, driven by the increasing trend of pet humanization and rising healthcare expenditure on companion animals. As urban households grow more inclined toward pet ownership, veterinary clinics are seeing higher patient volumes requiring fluid therapy, drug infusion, and post-surgical care. Infusion pumps play a critical role in managing conditions like kidney disease, cancer, and post-operative recovery in small animals. With their shorter recovery thresholds and sensitivity to dosage accuracy, the use of infusion technologies is becoming routine in small animal practices, reinforcing segmental growth.

Based on the end user:

• Veterinary Hospital & Clinics
• Animal Research Centres
• Others

Veterinary hospitals and clinics account for the largest end-user share in the  market, driven by their access to specialized staff, diagnostic infrastructure, and diverse patient caseloads. These facilities are central to both emergency and long-term care, utilizing infusion pumps extensively for hydration therapy, anaesthesia delivery, and post-operative drug administration. The increasing adoption of advanced, programmable infusion devices is further enabled by staff training and workflow integration in clinical environments. With a rising number of surgical procedures and chronic illness management cases in companion animals, hospitals and clinics remain the primary hubs for consistent and technology-driven infusion therapy.